Stockreport

NRx Soars as Drug Benefits Remdesivir-Treated Covid Patients [Business News Network (BNN) (Canada)]

Merck & Company, Inc. (new)  (MRK) 
Last merck & company, inc. (new) earnings: 4/28 06:45 am Check Earnings Report
US:NYSE Investor Relations: investors.merck.com/home/default.aspx
PDF Patients who received NRx's Zyesami after remdesivir had 2.5-fold increased odds of being alive and free of respiratory failure after 60 days, compared with those that [Read more]